Shortlist CARE awards 2017 | Pharma Intelligence

We are delighted to announce the finalists for the 2017 Clinical and Research Excellence Awards:

Best Patient Centric Clinical Trial

Braeburn Pharmaceuticals, Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients with Opioid Use Disorder

CK Aspire, Domiciliary Service on behalf of the Salford Lung Study (SLS) sponsored by GlaxoSmithKline (GSK)

Janssen Research & Development, A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 (Palucorcel) in Participants with Geographic Atrophy (PRELUDE)

PPD, CRADLE

Don’t forget to book your place to attend.

Best Patient-Focused Technological Development

AMRA, AMRA® Profiler Research

CRF Health, TrialConsent™, electronic informed consent platform

NorthWest EHealth, Linked Database System

PAREXEL International, Consent+

Don’t forget to book your place to attend.

Best Sponsor-Focused Technological Development

Covance, Xcellerate® Medical Review

Cytel, East 6.4 Team

goBalto, goBalto Select

IBM Watson Health & Novartis & Highlands Oncology, Watson Clinical Trial Matching Team

Medidata Solutions, Medidata Balance: Pooling Trial Supplies at Sites

Don’t forget to book your place to attend.

Clinical Partnership of the Year – Sponsored by EBD Group

AstraZeneca Business Development Project Team

Bellerophon Therapeutics and Worldwide Clinical Trials

Medidata Solutions & TESARO

Novartis Pharma; Kenya Medical Research Institute Center for Clinical Research/Strathmore University; Kintampo Health Research Center; Ifakara Health Institute; Division of Clinical Pharmacology at the University of Cape Town; Addis Ababa University/ Regional Bioequivalence Center; African Institute of Biomedical Science and Technology, Clinical Pharmacology Capability Building in Sub-Saharan Africa

Don’t forget to book your place to attend.

Clinical Trial Result of the Year

Centrexion Therapeutics, TRIUMPH – Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects with Chronic, Moderate-to-Severe Osteoarthritis Knee Pain

Kiadis Pharma, Evaluation of the safety and efficacy of ATIR101™ in patients with a hematologic malignancy, who received a CD34-selected hematopoietic stem cell transplantation from a haploidentical donor

Kite Pharma, ZUMA-1 Pivotal CAR-T Therapy Trial of Axicabtagene Ciloleucel in Patients with Aggressive Non-Hodgkin Lymphoma (NHL)

Radius Health, Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women with Osteoporosis

TESARO, Niraparib NOVA Trial

Don’t forget to book your place to attend.

Excellence in Rare Disease Drug Development

Onxeo, AsiDNA, a first-in-class signal-interfering DNA repair pathway inhibitor for cancer treatment

Retrophin, Phase 2 Study (NCT01613118) of Sparsentan for focal segmental glomerulosclerosis (FSGS)

Tocagen, Toca 511 + Toca FC for recurrent high grade glioma

Don’t forget to book your place to attend.

Most Innovative Clinical Trial Design

Braeburn Pharmaceuticals, A Phase III Trial of CAM2038, a Once-Weekly and Once-Monthly, Long-Acting Subcutaneous Injectable Depot of Buprenorphine Treatment for Adult Outpatients with Opioid Use Disorder

Ipca Laboratories, Evaluation of Efficacy and Safety of Spironolactone + Chlorthalidone Combination in the Treatment of Patients with Essential Hypertension, Pre-diabetes, and Insulin Resistance: A Double-blind, Randomized Comparison with Individual Monotherapies

Ipca Laboratories, Efficacy and Safety of Hydroxychloroquine in Prevention of Diabetes in Patients with Pre-diabetic Dyslipidemia: A Double Blind, Randomized Comparison with Atorvastatin Alone

Multiple Myeloma Research Foundation, CoMMpass ((Relating) Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profiles) study

Tracon Pharmaceuticals (in collaboration with Cytel), A Randomized Phase 3 Trial of TRC105 and Pazopanib Versus Pazopanib alone in Patients with Advanced Angiosarcoma (TAPPAS)

Don’t forget to book your place to attend.

Most Successful Early Phase Trial (Preclinical & Phase I)

Nektar, NKTR-214 in Subjects with Locally Advanced or Metastatic Solid Tumor Malignancies

Onxeo, A first-in-human Phase I clinical trial of AsiDNA in patients with metastatic melanoma

Tocagen, Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Don’t forget to book your place to attend.

Pharma/Biotech Product Development Team of the Year – Sponsored by Cytel

ICON/Pfizer Tofa Oral Strategy Team

Retrophin, Sparsentan Product Development Team

TESARO, Niraparib Product Development Team

Don’t forget to book your place to attend.

Marquee Award for R&D Excellence

Shortlist will be announced soon.

Don’t forget to book your place to attend.

Lifetime Achievement Award

To be announced on the evening.

Winners will be announced at the awards ceremony and dinner on 5 April, at the State Room in Boston.

Don’t forget to book your place to attend.

Good luck to all of our finalists!

CARE Awards Shortlist 2017

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Report store